Načítá se...
Evaluation of confirmatory data following the Article 12 MRL review for fludioxonil
The applicant Syngenta submitted a request to the competent national authority in France to evaluate the confirmatory data that were identified in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available. The applicant provided residue...
Uloženo v:
| Vydáno v: | EFSA J |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7009037/ https://ncbi.nlm.nih.gov/pubmed/32626430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2903/j.efsa.2019.5812 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|